Results 221 to 230 of about 24,588 (279)

Discontinuation of biologic therapy in severe asthma: Evidence and strategies for safe withdrawal: A scoping review. [PDF]

World Allergy Organ J
Ramirez-Villamizar J, Ibarra-Enríquez CD, Galindo-Sánchez JS, Serrano-Reyes C, Fernández-Trujillo L.   +4 more
europepmc   +1 more source

Deflazacort: a possible alternative in corticosteroid allergy [PDF]

, 2010
Almeida, E, Carrapatoso, I, Chieira, C, Faria, E, Geraldes, E, Sousa, NG   +5 more
core  

Successful Oral Immunotherapy (OIT) Due to Anti-IgE Protection. [PDF]

J Clin Med
Yoosefi Moridani M, Lau S, Beyer K.
europepmc   +1 more source

Postural tremor due to use of omalizumab

, 2016
Mehmet Güney Şenol, Ali Kutlu
openalex   +1 more source

Antihistamines and omalizumab combination treatment in patients with chronic spontaneous urticaria: Real-world experience from a tertiary care hospital. [PDF]

North Clin Istanb
Mentesoglu D, Kurmus GI, Kartal SP.
europepmc   +1 more source

Current treatment practices and efficacy in solar urticaria: insights from a patient survey. [PDF]

Front Immunol
Kiefer L, Aulenbacher F, Terhorst-Molawi D, Giménez-Arnau AM, Gonçalo M, Fukunaga A, Kocatürk Göncü E, Kulthanan K, McSweeney S, Röckmann H, Weller K, Rhodes LE, Pereira MP.   +12 more
europepmc   +1 more source

Comparative analysis of the manufacturing carbon footprint of biologics for severe asthma. [PDF]

BMJ Open
Taylor H, Rahman N.
europepmc   +1 more source

Optimizing Biologic Treatment Selection in Chronic Rhinosinusitis with Nasal Polyps: A Network Meta-Analysis of Efficacy and Safety Across 22 RCTs. [PDF]

Pharmaceuticals (Basel)
Safia A, Khater A, Abd Elhadi U, Merchavy S, Karam M.   +4 more
europepmc   +1 more source

Long-Term Omalizumab Use, Chronic Spontaneous Urticaria and COVID-19

Öner Özdemır
openalex   +2 more sources

Turnip and zucchini: new foods in the latex-fruit syndrome [PDF]

, 2007
Chieira, C, Loureiro, G, Lundberg, M, Pereira, C, Tavares, B   +4 more
core